Is rmti a buy

**Rockwell Medical (RMTI) appears to be a promising investment opportunity**, and here's why:

1. **Strong Financial Performance**: Rockwell Medical has reported significant improvements in key financial metrics. For the third quarter of 2024, the company reported net product sales of $28.3 million, a 31% increase over the same period in 2023. The gross profit surged by 183% to $6.2 million, resulting in a gross margin of 22%, up from 9% in the previous year. Net income for the quarter was $1.7 million, a substantial improvement from a net loss of $1.9 million in Q3 2023.
2. **Consistent Positive Earnings Surprises**: Rockwell Medical has a history of beating earnings estimates. In the last reported quarter, the company’s adjusted earnings of 1 cent exceeded the Zacks Consensus Estimate by 125%. The company has consistently beaten estimates in each of the trailing four quarters, with an average positive surprise of 87.92%.
3. **Strategic Initiatives**: Rockwell Medical is actively working on diversifying its product portfolio and expanding its market reach. The company has entered into a multi-million dollar distribution agreement with Nipro Medical Corporation and announced a product purchase agreement with a leading at-home and acute care dialysis manufacturer in the United States. These strategic moves are likely to boost the company's revenue and market position.
4. **Analyst Confidence**: The consensus rating for RMTI is "Strong Buy" with an average price target of $9, indicating significant upside potential from the current price. Additionally, the company's earnings estimates have improved from a loss of 3 cents per share to earnings of 1 cent for the third quarter over the past 90 days.
5. **Technical Indicators**: While there is no available data on RSI, MACD, and KDJ, the stock's price action indicates a potential bottom fishing opportunity. The closing price of $4.65 on November 11, 2024, is near the support level of $4.6 and below the resistance level of $5.15. This could suggest that the stock has bottomed out and is poised for a potential upward movement.

In conclusion, Rockwell Medical's strong financial performance, strategic initiatives, analyst confidence, and potential bottom fishing opportunity make it a compelling buy. Investors should consider their risk tolerance and investment horizon, as with any investment.